Eli Lilly and Company(@EliLillyandCo):Treating obesity & type 2 diabetes together can be challenging, but new research presented at #EASD2026 showed our investigational treatment, when taken at the highest dose, helped more than half of participants no longer have obesity, and nearly 40% reach a normal A1C.

Eli Lilly and Company

@EliLillyandCo

Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad)

加入 July 2010

1.2K 正在关注 146.3K 粉丝

Eli Lilly and Company@EliLillyandCo

2026.09.30 12:22

Treating obesity & type 2 diabetes together can be challenging, but new research presented at #EASD2026# showed our investigational treatment, when taken at the highest dose, helped more than half of participants no longer have obesity, and nearly 40% reach a normal A1C.

显示更多